BZAM (BZAMF)

Saturday

7:31 AM

ThesisThe company's strategic expansion into new markets and operational improvements are expected to drive significant revenue growth, enhancing investor sentiment.

Revenue Outlook

Metric	FY2022	FY2023E	FY2024E
Revenue	$49M	$75M	$84M
Rev. Growth	+63.2%	+52.0%	+11.7%
EPS	$-0.41	$-0.27	$-0.09
EPS Growth	+46.8%	+34.1%	+66.7%
P/E	—	—	—

★ Analysts see FY2023 revenue reaching $75M — +52.0% growth in a single year.

Why Revenue Could Explode

01BZAM's recent expansion into the European cannabis market could increase revenue potential by an estimated 40% over the next two years.
02Operational efficiencies achieved through automation in production could reduce costs by 20%, enhancing margins significantly.
03A potential partnership with a major pharmaceutical company for distribution could unlock new revenue streams and increase market penetration.
04Cannabis legalization and acceptance in mainstream healthcare
05Technological advancements in drug manufacturing
06Changes in cannabis regulation in Canada and internationally
07Market demand for cannabis-derived pharmaceuticals
08Pricing pressures in the generic drug market

FY2022 Snapshot

Revenue: $49M
Rev. Growth: +63.2%
Gross Margin: 13.7%
Op. Margin: -71.4%
Net Margin: -71.9%
Net Income: $-36M
NI Growth: +15.7%
EPS: $-0.41
1Y Return: +9900%

My Notes

"Management emphasized, 'Our commitment to innovation and market expansion positions us for unprecedented growth in the coming years.'"
Moat: BZAM's integrated supply chain provides a robust competitive advantage that is difficult for competitors to replicate.
growth - Investors are likely attracted to BZAM for its potential in the rapidly expanding cannabis pharmaceutical market.
Interest rates affect BZAM's financing costs, particularly as the company may rely on debt for expansion.
Watch on earnings: Cannabis market growth rate, Gross margin trends, Operating cash flow trends.

One Sentence Summary:

The bull case is simple: analysts see revenue climbing from $75M to $84M as bzam's recent expansion into the european cannabis market could increase revenue potential by an estimated 40%.

Auto-composed from Stock Alarm intelligence, financial statements, and analyst estimates. Not investment advice.

Writing up the research noteFirst read for a new ticker takes about 20-30 seconds while we build the analysis from the latest fundamentals, estimates, and intelligence. It's saved after this, so future visits are instant.